You are here

Combining opioid peptides and Nav1.7 blockers can obstruct pain

Editage Insights | 2015年12月7日 | 2,790 浏览次数
Combining opioid peptides and Nav1.7 blockers can block pain

Nav1.7 plays an important role in pain pathways, and individuals born with non-functioning Nav1.7 fail to experience pain. Although scientists have developed drugs that would block Nav1.7 in an attempt to block pain, they have met with little success. Rresearchers from University College London did further research on designing a new treatment for eliminating the feeling of pain. They made a significant observation that transgenetic mice with non-functioning Nav1.7 produced more opioid peptides than those with functioning Nav1.7 did. To test whether opioids are also responsible for cutting off pain, they gave the mice an opioide blocker, naloxone, and they found that Nav1.7 lacking mice became capable of feeling pain. The study confirmed that Nav1.7 and opioids together play an important role in painlessness. The team now hopes to get a patent on a novel treatment for pain management by combining low doses of opoids and Nav1.7 blockers. Moreover, this treatment has an edge over conventional opioid painkillers such as morphine that are damaging to humans when used over a long period of time.

Read more in Science Daily.   


《意得辑专家视点》深信知识需要开放给所有大众并传播,因此我们鼓励读者重复发表我们的内容,重复发表形式可为在线或印刷。我们采用知识共享(Creative Commons license),只要您遵守以下事项,即可免费重复发表我们的内容:
  • 作者信息:请尊重我们的作者,他们花费了时间精力为您撰写这些有价值的内容,重复发表时加注作者信息。
  • 意得辑专家视点:必须注明文章出自《意得辑专家视点》。
  • 表达您的情意:您可以加句“前往《意得辑专家视点》阅读全文”之类的话,啊,还有,别忘了加上文章链接。
  • 重复使用图片:要使用某些文章的图片必须事先取得许可,并加注图片原始出处。
  • 镶嵌代码:要重复使用这篇文章最简单的方式就是将下面的代码复制贴上您的页面!